Physician profile
Muhammad Naseeruddin
NPI 1194849224
$1,171.49
in general payments reported to CMS, 2019-2025
19 companies · $21.44 in 2025
The $21.44 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $82.08 · 2021: $19.13 · 2022: $188 · 2023: $247 · 2024: $282 · 2025: $21.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $549.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $197.98 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $170.05 | 2022-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $109.27 | 2019-2024 | Eliquis |
| Mylan Specialty L.P. | $106.45 | 2019-2020 | |
| Cumberland Pharmaceuticals, INC. | $87.28 | 2019-2023 | Caldolor |
| Abbvie INC. | $76.73 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $68.32 | 2019-2023 | |
| Vifor Pharma, INC. | $48.04 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $41.02 | 2019-2023 | Zerbaxa, Dificid |
| Novartis Pharmaceuticals Corporation | $38.26 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.71 | 2019 | |
| Medtronic Vascular, INC. | $33.07 | 2019 | |
| Medtronic, INC. | $30.73 | 2022 | |
| Amgen INC. | $27.84 | 2022 | |
| Heartflow, INC. | $25.36 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $20.29 | 2023 | Terlivaz |
| Allergan, INC. | $20.23 | 2019 | |
| Biomerieux INC | $18.59 | 2019 | |
| Neurelis, INC. | $18.27 | 2023 | Valtoco |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Naseeruddin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.